Back to search

Institutional Repository of Vilnius University

Visuomenėje įgytos pneumonijos gydymo veiksmingumo vertinimas /

Abstract

dc:description

Community acquired pneumonia is an infectious disease, which affects the parenchyma, and it occurs for a patient, which has not been in a hospital setting recently. The most common pathogen is Streptococcus pneumoniae. Based on the Lithuanian national treatment guidelines for community acquired pneumonia – amoxicillin is the most prescribed treatment option, because most pathogens are susceptible to β-lactam group antibiotics. There are no globally accepted criteria for evaluating the efficacy of treatment. Monitoring the progression of clinical symptoms, pneumonia and its complications, along with comorbidities, remains the most important aspects. Clinical stability ensures a successful treatment course. During treatment, reaching clinical stability demonstrates treatment efficacy. Additionally, if needed, blood markers are used for the evaluation of possible complications. Chest X-ray remains the most prominent tool for the assessment of the disease, however, clinical symptoms improvement is noticed first. Chest ultrasound is on the rise, because it can easily detect early potential complications and assess the progression of community acquired pneumonia.

Degree

thesis:*
Grantor dc:publisher
Institutional Repository of Vilnius University
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Ulozas, Ignas,

Rights

dc:rights
Statement dc:rights
  • info:eu-repo/semantics/openAccess
Language dc:language
lit

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Vilnius University
Base URL
epublications.vu.lt/oai
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Ulozas, Ignas,. Visuomenėje įgytos pneumonijos gydymo veiksmingumo vertinimas /. Institutional Repository of Vilnius University, 2022. https://repository.vu.lt/VU:ELABAETD192962627&prefLang=en_US